Prescott Group Capital Management L.L.C. Buys 189,141 Shares of The Beauty Health Company $SKIN

Prescott Group Capital Management L.L.C. lifted its stake in The Beauty Health Company (NASDAQ:SKIN) by 29.2% in the second quarter, Holdings Channel.com reports. The firm owned 835,939 shares of the company’s stock after buying an additional 189,141 shares during the period. Prescott Group Capital Management L.L.C.’s holdings in Beauty Health were worth $1,597,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the stock. Grimes & Company Inc. lifted its position in Beauty Health by 85.2% in the second quarter. Grimes & Company Inc. now owns 406,987 shares of the company’s stock worth $777,000 after buying an additional 187,226 shares during the last quarter. Simplicity Wealth LLC bought a new position in Beauty Health during the second quarter valued at $49,000. Newman Dignan & Sheerar Inc. raised its stake in shares of Beauty Health by 28.1% in the second quarter. Newman Dignan & Sheerar Inc. now owns 91,144 shares of the company’s stock valued at $174,000 after acquiring an additional 20,000 shares during the period. Kapitalo Investimentos Ltda bought a new stake in shares of Beauty Health in the 2nd quarter worth about $60,000. Finally, Goldman Sachs Group Inc. boosted its stake in shares of Beauty Health by 5.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 665,706 shares of the company’s stock worth $892,000 after purchasing an additional 31,880 shares during the period. Institutional investors own 93.26% of the company’s stock.

Beauty Health Stock Performance

Beauty Health stock opened at $1.40 on Friday. The company has a debt-to-equity ratio of 4.91, a quick ratio of 4.15 and a current ratio of 5.15. The company has a market capitalization of $177.55 million, a PE ratio of -6.36 and a beta of 1.19. The company has a 50 day moving average price of $1.80 and a 200-day moving average price of $1.75. The Beauty Health Company has a fifty-two week low of $0.78 and a fifty-two week high of $2.69.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings data on Thursday, November 6th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.01). The firm had revenue of $70.66 million for the quarter, compared to analysts’ expectations of $68.33 million. Beauty Health had a negative return on equity of 20.42% and a negative net margin of 3.87%. Beauty Health has set its FY 2025 guidance at EPS. As a group, equities analysts forecast that The Beauty Health Company will post -0.25 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. TD Cowen increased their price objective on shares of Beauty Health from $2.00 to $2.50 and gave the stock a “hold” rating in a research report on Monday, September 22nd. Wall Street Zen downgraded Beauty Health from a “buy” rating to a “hold” rating in a report on Saturday. Cowen restated a “hold” rating on shares of Beauty Health in a report on Monday, September 22nd. Zacks Research raised Beauty Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 21st. Finally, Roth Capital initiated coverage on Beauty Health in a research report on Friday, September 19th. They set a “buy” rating and a $3.50 target price for the company. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Beauty Health currently has an average rating of “Hold” and an average target price of $2.81.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.